Bioventix (LON:BVXP) Stock Jumps 2.5% – What’s Next?

Bioventix PLC (LON:BVXP – Get Free Report)’s stock price rose 2.5% during trading on Tuesday. The stock traded as high as GBX 1,998.23 and last traded at GBX 1,998.23. 45,612 shares traded hands during trading, an increase of 260% from the average session volume of 12,685 shares. The stock had previously closed at GBX 1,950.

Bioventix Stock Performance

The stock has a 50 day moving average of GBX 1,783.86 and a 200 day moving average of GBX 1,670.81. The stock has a market capitalization of £104.41 million, a P/E ratio of 13.91 and a beta of 0.54. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.50 and a current ratio of 8.53.

Bioventix (LON:BVXP – Get Free Report) last announced its earnings results on Monday, October 26th. The biotechnology company reported GBX 145.74 earnings per share for the quarter. Bioventix had a return on equity of 67.81% and a net margin of 58.70%. The firm had revenue of GBX 1,297 million for the quarter. Equities analysts predict that Bioventix PLC will post 166.31 EPS for the current year.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Further Reading

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.